ATXN3
ATXN3 (ataxin 3, also known as ATX3, JOS, SCA3 and MJD) is a deubiquitinating enzyme that binds and trims long polyubiquitin chains. It contributes to protein homeostasis, transcription, autophagy and the handling of misfolded chaperone substrates. Browse Assay Genie's current range of ATXN3 research reagents below, or read on for the biology behind the target.
ATXN3 is a deubiquitinating enzyme involved in maintaining protein homeostasis, regulating transcription and the cytoskeleton, supporting myogenesis and degrading misfolded chaperone substrates. It binds long polyubiquitin chains and trims them, with weak or no activity against chains of four or fewer ubiquitins. In chaperone-substrate quality control it interacts with STUB1/CHIP: it is recruited to monoubiquitinated STUB1/CHIP and limits the length of the ubiquitin chain attached to STUB1/CHIP substrates, preventing further chain extension.
The ATXN3 protein also acts in signalling and gene regulation. It interacts with key regulators of transcription and represses transcription, acting as a histone-binding protein. It is a negative regulator of mTORC1 signalling during amino acid deprivation, deubiquitinating RHEB and so promoting RHEB inactivation by the TSC-TBC complex. It also regulates autophagy by deubiquitinating Lys-402 of BECN1, which stabilises BECN1. UniProt lists its subcellular locations as the nucleus matrix, the nucleus and the lysosome membrane.
The ATXN3 gene is the Ataxin 3 family member historically named for Machado-Joseph disease (spinocerebellar ataxia 3), an autosomal dominant neurological disorder. The coding region contains a (CAG)n repeat; expansion from the normal 12-44 repeats to 52-86 is one cause of the disease, and a larger repeat number correlates with an earlier age of onset. Alternatively spliced transcript variants encoding different isoforms have been described. Mouse and rat both carry an orthologous gene, Atxn3.
ATXN3 repeat expansion causes Machado-Joseph disease, making the protein central to studies of spinocerebellar ataxia 3 and age of onset.
As a deubiquitinase that trims long polyubiquitin chains and works with STUB1/CHIP, ATXN3 is studied in the degradation of misfolded chaperone substrates.
ATXN3 deubiquitinates BECN1 and RHEB, linking it to autophagy regulation and to mTORC1 control under amino acid deprivation.
ATXN3 binds histones, interacts with transcriptional regulators and represses transcription, a role relevant to chromatin and gene expression studies.
ATXN3 is a deubiquitinating enzyme that binds long polyubiquitin chains and trims them. It supports protein homeostasis, represses transcription as a histone-binding protein, regulates autophagy through BECN1, and limits mTORC1 signalling by deubiquitinating RHEB when amino acids are scarce.
ATXN3 is also called ataxin 3, ATX3, JOS, SCA3 and MJD. The earlier HGNC name was Machado-Joseph disease (spinocerebellar ataxia 3, olivopontocerebellar ataxia 3, autosomal dominant, ataxin 3). Alternative splicing produces different isoforms, so check the datasheet of any product for its validated reactivity.
Expansion of the (CAG)n repeat in the ATXN3 coding region, from the normal 12-44 to 52-86 repeats, is one cause of Machado-Joseph disease, also called spinocerebellar ataxia 3. Higher repeat numbers correlate with earlier onset. Mouse and rat have an Atxn3 ortholog.
Other ataxin family proteins associated with spinocerebellar ataxias and neurodegeneration research.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P54252; product specifications from Assay Genie datasheets.